XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Business Segments (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2023
Business Segments |
Schedule of information regarding reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |  | Six Months
For the Periods Ended December 31 |  | 2023 |  | 2022 |  | 2023 |  | 2022
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Animal Health | ​ | $ | 173,104 | ​ | $ | 163,803 | ​ | $ | 333,634 | ​ | $ | 318,662
Mineral Nutrition | ​ |  | 61,347 | ​ |  | 61,644 | ​ |  | 117,373 | ​ |  | 121,290
Performance Products | ​ |  | 15,492 | ​ |  | 19,199 | ​ |  | 30,285 | ​ |  | 37,215
Total segments | ​ | $ | 249,943 | ​ | $ | 244,646 | ​ | $ | 481,292 | ​ | $ | 477,167
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 7,348 | ​ | $ | 6,934 | ​ | $ | 14,697 | ​ | $ | 13,845
Mineral Nutrition | ​ |  | 660 | ​ |  | 659 | ​ |  | 1,306 | ​ |  | 1,314
Performance Products | ​ |  | 433 | ​ |  | 453 | ​ |  | 859 | ​ |  | 895
Total segments | ​ | $ | 8,441 | ​ | $ | 8,046 | ​ | $ | 16,862 | ​ | $ | 16,054
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 39,299 | ​ | $ | 37,059 | ​ | $ | 67,793 | ​ | $ | 64,023
Mineral Nutrition | ​ |  | 3,507 | ​ |  | 4,399 | ​ |  | 6,388 | ​ |  | 9,696
Performance Products | ​ |  | 817 | ​ |  | 2,292 | ​ |  | 2,226 | ​ |  | 4,656
Total segments | ​ | $ | 43,623 | ​ | $ | 43,750 | ​ | $ | 76,407 | ​ | $ | 78,375
Reconciliation of income (loss) before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income (loss) before income taxes | ​ | $ | 3,565 | ​ | $ | 12,109 | ​ | $ | (8,414) | ​ | $ | 17,526
Interest expense, net | ​ |  | 4,659 | ​ |  | 3,884 | ​ |  | 9,223 | ​ |  | 6,951
Depreciation and amortization – Total segments | ​ |  | 8,441 | ​ |  | 8,046 | ​ |  | 16,862 | ​ |  | 16,054
Depreciation and amortization – Corporate | ​ |  | 469 | ​ |  | 453 | ​ |  | 919 | ​ |  | 895
Corporate costs | ​ | ​ | 14,171 | ​ | ​ | 12,838 | ​ | ​ | 28,304 | ​ | ​ | 25,329
Acquisition-related cost of goods sold | ​ | ​ | 310 | ​ | ​ | — | ​ | ​ | 310 | ​ | ​ | —
Pension settlement cost | ​ | ​ | 249 | ​ | ​ | — | ​ | ​ | 10,674 | ​ | ​ | —
Brazil employment taxes | ​ | ​ | 4,202 | ​ | ​ | — | ​ | ​ | 4,202 | ​ | ​ | —
Stock-based compensation | ​ | ​ | 80 | ​ | ​ | — | ​ | ​ | 161 | ​ | ​ | —
Environmental remediation costs | ​ | ​ | — | ​ | ​ | 6,569 | ​ | ​ | — | ​ | ​ | 6,569
Foreign currency losses (gains), net | ​ |  | 7,477 | ​ |  | (149) | ​ |  | 14,166 | ​ |  | 5,051
Adjusted EBITDA – Total segments | ​ | $ | 43,623 | ​ | $ | 43,750 | ​ | $ | 76,407 | ​ | $ | 78,375
Schedule of identifiable assets | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, |  | June 30,
As of |  | 2023 |  | 2023
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 694,383 | ​ | $ | 698,522
Mineral Nutrition | ​ |  | 71,755 | ​ |  | 75,814
Performance Products | ​ |  | 48,879 | ​ |  | 49,678
Total segments | ​ |  | 815,017 | ​ |  | 824,014
Corporate | ​ |  | 157,691 | ​ |  | 147,383
Total | ​ | $ | 972,708 | ​ | $ | 971,397

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration